Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, is published from CASPIAN on JTO as first author from CHCWM. DR. Chen reports this is the first time that immunotherapy plus chemotherapy works in small cell lung cancer patients with brain mets.
“Impact of brain metastases on treatment patterns and outcomes with first-line durvalumab plus platinum-etoposide in extensive-stage SCLC (CASPIAN)” To read the abstract, click here
Founded in 1979, CHCWM has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families. Thanks to the hard work of our growing staff, CHCWM has been named one of the Nation’s Best and Brightest Companies to Work For®. To learn more about CHCWM, visit chcwm.com.
Marketing Coordinator, email@example.com